about
Current Concepts in Multiple Sclerosis: Autoimmunity Versus OligodendrogliopathyPopulation-wide principal component-based quantification of blood-brain-barrier dynamics in multiple sclerosisThe Neurophysiologist Perspective into MS PlasticityNew and emerging immune-targeted drugs for the treatment of multiple sclerosisTertiary Lymphoid Organs in Central Nervous System AutoimmunityEpigenetic Drugs for Multiple SclerosisPathology of multiple sclerosis: where do we stand?Modeling the distribution of new MRI cortical lesions in multiple sclerosis longitudinal studiesDiffusely abnormal white matter in multiple sclerosis: further histologic studies provide evidence for a primary lipid abnormality with neurodegeneration.[Ultrahigh field MRI in context of neurological diseases].Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) studyStructural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study.Imaging as an Outcome Measure in Multiple Sclerosis.Oligodendroglia in cortical multiple sclerosis lesions decrease with disease progression, but regenerate after repeated experimental demyelinationCortical injury in multiple sclerosis; the role of the immune system.Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?Meningeal and cortical grey matter pathology in multiple sclerosis.The neuropathological basis of clinical progression in multiple sclerosis.Advanced MRI unravels the nature of tissue alterations in early multiple sclerosisMeningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.Patients with migraine do not have MRI-visible cortical lesions.Clinical and magnetic resonance imaging (MRI) distinctions between tumefactive demyelination and brain tumors in children.Cortical relapses in multiple sclerosis.Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortexClinical trials in progressive multiple sclerosis: lessons learned and future perspectivesInflammatory cortical demyelination in early multiple sclerosis.Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.Reliability of cortical lesion detection on double inversion recovery MRI applying the MAGNIMS-Criteria in multiple sclerosis patients within a 16-months period.Lipoic acid reduces inflammation in a mouse focal cortical experimental autoimmune encephalomyelitis model.A Distinct Class of Antibodies May Be an Indicator of Gray Matter Autoimmunity in Early and Established Relapsing Remitting Multiple Sclerosis Patients.Quantitative MRI demonstrates abnormality of the fornix and cingulum in multiple sclerosisIn vivo evidence of disseminated subpial T2* signal changes in multiple sclerosis at 7 T: a surface-based analysis.Visualization of intra-thalamic nuclei with optimized white-matter-nulled MPRAGE at 7T.Multiple sclerosis in 2011: Advances in therapy, imaging and risk factors in MS.A further TWEAK to multiple sclerosis pathophysiology.MRI evidence of acute inflammation in leukocortical lesions of patients with early multiple sclerosis.Progressive MS: from pathophysiology to drug discovery.MRI evaluation of thalamic volume differentiates MS from common mimics.Adipose-derived mesenchymal stem cells modulate the immune response in chronic experimental autoimmune encephalomyelitis model.Spring cleaning: time to rethink imaging research lines in MS?
P2860
Q22252578-6734E2DD-4FC5-4EDC-9893-3D588017BAF9Q24632212-D4F36A12-52A6-473D-998E-C58106B3FA74Q26782926-7C36ECA2-8DAD-4529-A962-40CFECC4B271Q26997067-F978074C-E097-4AC3-9B2F-468ADBE6817EQ28071379-DCE42408-BF45-4CB3-8862-82383D080E9DQ28076395-42002D69-35A2-4829-A661-FAE74C4E6B61Q28296052-65E14E0F-BDD0-4027-8DAC-B0C43509623EQ28743636-0B72207E-1A63-4883-8841-EBC6EBF1F8D9Q30581773-C6E46611-17D5-4EE3-B53C-F05A36862D29Q30759627-B3048899-CA96-4C34-BEC8-254342A81C3DQ31038347-5BDFD4FE-2C00-4E40-83B9-7167C2B6F3E8Q31042055-7A8545EE-39AF-4F8C-BE5F-34FC580B5FD8Q31134617-90DBDCFA-270B-4ABD-A7CC-7F123B4D9CEAQ33917691-367AE444-7B70-49D3-A105-E3A79FBB5210Q34092684-D2C42F25-D5BC-465E-A96F-1D0C8499ABC3Q34156824-FBB2EAA1-DEBE-4C20-8D35-6C2D29C98B25Q34187428-8E8739D6-6E54-4C95-875B-7C3755C23559Q34188436-98080E39-7215-467F-82D7-61C807A97BBCQ34286763-EC870078-B285-49EA-A5B5-8CF1502C0366Q34295012-218808E9-54F7-4F3E-A947-E7561FEB6B26Q34309543-F5BB87D6-7EDF-4DC2-B0EC-0B151931A167Q34375230-7EC083F9-85E2-4860-B3E9-7673D28CB509Q34467914-6EE8B263-4AB9-4435-8C37-B379D244FEE8Q34543420-64F552F0-3999-4C15-AA35-127A627B2602Q35182733-7DEC7B4C-CD83-4B69-8C57-9477B71AD309Q35764685-89C51E91-9D13-4EE1-B2DC-2A0D52FC2B18Q35867011-7CF0EE05-94FC-49CE-A591-A3297465CBEEQ36290239-9D52CA1C-6045-4117-9436-99A6894A8F34Q36333347-9CC1B73B-C13A-4B86-88A0-7796ACB1B4CAQ36455070-F3AE25B1-248B-4604-8225-671FFC5C5D05Q36651323-CE7FE53B-9AC1-4916-BDD8-671D4547A439Q37296089-9F28B27F-F148-4ED3-9AA4-3197EAF8AE51Q37590821-71D7DAF5-DAB9-46EB-8318-64EEFB187175Q37974487-4C7C47BD-1989-4C71-AE50-8F48EAE0F9A0Q38123074-F2CA0802-24AD-4B5C-94F4-3C857FFF72EDQ38373659-3867E723-E173-4CA9-B545-D1A32B6AA90BQ38585418-F2877D88-236F-4186-849B-D4284E98434BQ38648892-ED6BD1D9-01CF-45DB-A8F6-083A4444FA47Q38693428-0C5B3C39-9C17-47B5-A32A-08304A2E3137Q38737202-EFD42612-E3AD-430F-A545-B64F9B959326
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cortical lesions in multiple sclerosis.
@ast
Cortical lesions in multiple sclerosis.
@en
type
label
Cortical lesions in multiple sclerosis.
@ast
Cortical lesions in multiple sclerosis.
@en
prefLabel
Cortical lesions in multiple sclerosis.
@ast
Cortical lesions in multiple sclerosis.
@en
P2093
P2860
P356
P1476
Cortical lesions in multiple sclerosis.
@en
P2093
Massimiliano Calabrese
Massimo Filippi
Paolo Gallo
P2860
P2888
P304
P356
10.1038/NRNEUROL.2010.93
P407
P577
2010-07-13T00:00:00Z
P6179
1004184537